Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

Fitzgerald, Felicity C; Lhomme, Edouard; Harris, Kathryn; Kenny, Julia; Doyle, Ronan; Kityo, Cissy; Shaw, Liam P; Abongomera, George; Musiime, Victor; Cook, Adrian; +9 more... Brown, Julianne R; Brooks, Anthony; Owen-Powell, Ellen; Gibb, Diana M; Prendergast, Andrew J; Sarah Walker, A; Thiebaut, Rodolphe; Klein, Nigel; CHAPAS-3 Trial Team; (2019) Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV. JOURNAL OF INFECTIOUS DISEASES, 219 (1). pp. 89-100. ISSN 0022-1899 DOI: https://doi.org/10.1093/infdis/jiy495 Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4652527/

[1]  E. Maidji,et al.  Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction , 2017, PLoS pathogens.

[2]  M. Netea,et al.  Mortality in children with complicated severe acute malnutrition is related to intestinal and systemic inflammation: an observational cohort study12 , 2016, The American journal of clinical nutrition.

[3]  A. d’Arminio Monforte,et al.  Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy , 2016, AIDS.

[4]  S. Moreno,et al.  Visceral leishmaniasis as an independent cause of high immune activation, T‐cell senescence, and lack of immune recovery in virologically suppressed HIV‐1‐coinfected patients , 2015, HIV medicine.

[5]  M. Lederman,et al.  Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection. , 2014, The Journal of infectious diseases.

[6]  L. Madrid,et al.  Microbial translocation and T cell activation are not associated in chronic HIV-infected children , 2014, AIDS.

[7]  M. Nakakeeto,et al.  Prevalence of Bloodstream Pathogens Is Higher in Neonatal Encephalopathy Cases vs. Controls Using a Novel Panel of Real-Time PCR Assays , 2014, PloS one.

[8]  P. Sax,et al.  Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 , 2014, Journal of acquired immune deficiency syndromes.

[9]  S. Gianella,et al.  An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia , 2014, Mucosal Immunology.

[10]  N. Klein,et al.  Short communication: Evidence that microbial translocation occurs in HIV-infected children in the United Kingdom. , 2013, AIDS research and human retroviruses.

[11]  D. Douek,et al.  Immune activation and HIV persistence: implications for curative approaches to HIV infection , 2013, Immunological reviews.

[12]  C. Rouzioux,et al.  The Th17/Treg Ratio, IL-1RA and sCD14 Levels in Primary HIV Infection Predict the T-cell Activation Set Point in the Absence of Systemic Microbial Translocation , 2013, PLoS pathogens.

[13]  D. Neau,et al.  Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort. , 2013, The Journal of infectious diseases.

[14]  G. Freeman,et al.  Down-Regulation of CTLA-4 by HIV-1 Nef Protein , 2013, PloS one.

[15]  W. Borkowsky,et al.  Increased Gut Microbial Translocation in HIV-infected Children Persists in Virologic Responders and Virologic Failures After Antiretroviral Therapy , 2012, The Pediatric infectious disease journal.

[16]  L. Montaner,et al.  Increased Microbial Translocation in ≤180 Days Old Perinatally Human Immunodeficiency Virus-positive Infants as Compared With Human Immunodeficiency Virus-exposed Uninfected Infants of Similar Age , 2011, The Pediatric infectious disease journal.

[17]  A. d’Arminio Monforte,et al.  Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy , 2011, PloS one.

[18]  Handan Wand,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[19]  T. Quinn,et al.  Is microbial translocation a cause or consequence of HIV disease progression? , 2011, The Journal of infectious diseases.

[20]  S. Deeks,et al.  HIV infection, inflammation, immunosenescence, and aging. , 2011, Annual review of medicine.

[21]  G. Poli,et al.  Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. , 2010, The Journal of infectious diseases.

[22]  O. Laeyendecker,et al.  C-Reactive Protein Levels Increase During HIV-1 Disease Progression in Rakai, Uganda, Despite the Absence of Microbial Translocation , 2010, Journal of acquired immune deficiency syndromes.

[23]  M. Wallet,et al.  Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy , 2010, AIDS.

[24]  B. Clotet,et al.  CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART , 2010, AIDS.

[25]  P. Klenerman,et al.  HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells , 2010, AIDS.

[26]  R. Kaul,et al.  HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers , 2009, PloS one.

[27]  J. Margolick,et al.  Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa , 2009, Proceedings of the National Academy of Sciences.

[28]  M. Lederman,et al.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.

[29]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[30]  C. Tincati,et al.  Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy , 2008, AIDS.

[31]  Steven Wolinsky,et al.  Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients , 2008, PloS one.

[32]  C. Giaquinto,et al.  Immune reconstitution in human immunodeficiency virus type 1‐infected children with different virological responses to anti‐retroviral therapy , 2007, Clinical and experimental immunology.

[33]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[34]  Jeffrey N. Martin,et al.  Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses , 2006, AIDS.

[35]  R. Knight,et al.  UniFrac: a New Phylogenetic Method for Comparing Microbial Communities , 2005, Applied and Environmental Microbiology.

[36]  N. Jones,et al.  T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. , 2005, The Journal of infectious diseases.

[37]  B. Freedman,et al.  Macrophage activation through CCR5‐ and CXCR4‐mediated gp120‐elicited signaling pathways , 2003, Journal of leukocyte biology.

[38]  K. Harris,et al.  Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. , 2003, Journal of medical microbiology.

[39]  J. Moore,et al.  Risk Assessment Models and Contamination Management: Implications for Broad-Range Ribosomal DNA PCR as a Diagnostic Tool in Medical Bacteriology , 2002, Journal of Clinical Microbiology.

[40]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[41]  C. Estcourt,et al.  CD14lowCD16high: A cytokine‐producing monocyte subset which expands during human immunodeficiency virus infection , 1995, European journal of immunology.

[42]  J. Mege,et al.  Increased interleukin-6 production is associated with disease progression in HIV infection. , 1991, AIDS.

[43]  M. Kazatchkine,et al.  HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1 alpha in vitro. , 1989, AIDS.

[44]  A. Walker,et al.  Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial , 2016, The Lancet. Infectious diseases.

[45]  F. Månsson,et al.  Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. , 2010, The Journal of infectious diseases.

[46]  Peter Piot,et al.  Joint United Nations Program on HIV/AIDS (UNAIDS) , 1997 .